Literature DB >> 7686064

How should new treatments for benign prostatic hyperplasia be assessed?

D Kirk.   

Abstract

Entities:  

Mesh:

Year:  1993        PMID: 7686064      PMCID: PMC1677759          DOI: 10.1136/bmj.306.6888.1283

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

1.  Medical treatment for benign prostatic hyperplasia.

Authors:  C Chapple
Journal:  BMJ       Date:  1992-05-09

2.  Outcome of elective prostatectomy.

Authors:  D E Neal; P D Ramsden; L Sharples; A Smith; P H Powell; R A Styles; R J Webb
Journal:  BMJ       Date:  1989-09-23

3.  Permanently implanted urethral stent for prostatic obstruction in the unfit patient. Preliminary report.

Authors:  C R Chapple; E J Milroy; D Rickards
Journal:  Br J Urol       Date:  1990-07

4.  Transurethral microwave treatment for benign prostatic hypertrophy: a randomised controlled clinical trial.

Authors:  A S Bdesha; C J Bunce; J P Kelleher; M E Snell; J Vukusic; R O Witherow
Journal:  BMJ       Date:  1993-05-15

5.  Terazosin in the treatment of benign prostatic hyperplasia: a multicentre, placebo-controlled trial.

Authors:  S N Lloyd; J F Buckley; C P Chilton; I Ibrahim; A V Kaisary; D Kirk
Journal:  Br J Urol       Date:  1992-11

6.  A new look at bladder neck obstruction by the food and drug administration regulators: guide lines for investigation of benign prostatic hypertrophy.

Authors:  S Boyarsky; G Jones; D F Paulson; G R Prout
Journal:  Trans Am Assoc Genitourin Surg       Date:  1976
  6 in total
  2 in total

1.  Benign prostatic hyperplasia. Poorly correlated with symptoms.

Authors:  P Abrams
Journal:  BMJ       Date:  1993-07-17

2.  Mortality from benign prostatic hyperplasia: worldwide trends 1950-92.

Authors:  C La Vecchia; F Levi; F Lucchini
Journal:  J Epidemiol Community Health       Date:  1995-08       Impact factor: 3.710

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.